List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 19 studies with search of: Open Studies | "von Willebrand Disease"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Study With OPTIVATE® in People With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: Optivate
2 Recruiting Study of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (vWF/FVIII), Biostate®, in Subjects With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Biostate®
3 Recruiting Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Condition: Von Willebrand Disease
Interventions: Biological: Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII);   Biological: Marketed plasma-derived VWF/FVIII concentrate
4 Recruiting National Study of Moderate and Severe Von Willebrand Disease in the Netherlands
Condition: Von Willebrand Disease
Intervention:
5 Recruiting IL-11 in Adults With Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Drug: Neumega (Oprelvekin, Interleukin 11, IL-11)
6 Recruiting IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia
Condition: Von Willebrand Disease
Intervention: Drug: Neumega (Oprelvekin, Interleukin 11, IL-11)
7 Not yet recruiting Interleukin-11 (IL-11) in Moderate or Mild Hemophilia A or Von Willebrand Disease (VWD) Unresponsive to Desmopressin Acetate (DDAVP)
Conditions: Hemophilia A;   Von Willebrand Disease
Intervention: Biological: Neumega (Oprelvekin, Interleukin 11, IL-11)
8 Recruiting Optivate in People With Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Drug: Optivate
9 Recruiting The Von Willebrand Disease (VWD) International Prophylaxis Study
Condition: Von Willebrand Disease
Intervention: Drug: VWF/FVIII products (see below)
10 Recruiting Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients
Condition: Type 3 Von Willebrand Disease
Intervention: Drug: Plasma-derived FVIII/VWF concentrate
11 Recruiting Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle
Condition: Von Willebrand Disease
Intervention:
12 Recruiting Changes in Bleeding and Clotting During the Menstrual Cycle
Conditions: Von Willebrand's Disorder;   Healthy
Intervention:
13 Recruiting Study of ADAMTS-13 Activity, Von Willebrand Factor and Platelet-Monocyte Aggregation in Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention: Other: Blood draws
14 Recruiting Levels of Von Willebrand Factor Multimers and VWF-Cleaving Protease (ADAMTS-13) in Preterm and Neonate
Condition: Von Willebramd Factor
Intervention:
15 Recruiting Acquired Von Willebrand Syndrome in Severe Aortic Stenosis
Conditions: Bleeding;   Von Willebrand Syndrome;   Aortic Stenosis
Intervention:
16 Recruiting Study of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (vWF/FVIII), Biostate®, in Subjects With Haemophilia A
Condition: Hemophilia A
Interventions: Biological: Biostate® [SP];   Biological: Biostate® [RP]
17 Recruiting Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy
Conditions: Intracranial Embolism;   Cerebral Thromboembolism;   Carotid Stenosis
Interventions: Drug: ARC1779 Injection;   Drug: Placebo (normal saline)
18 Recruiting CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study
Condition: Stable Angina
Intervention:
19 Recruiting Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung Disease
Conditions: Interstitial Lung Disease;   Pulmonary Hypertension;   Biomarkers
Intervention:

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services